Diet Coke’s decision to launch a slate of new flavors had some critics wondering if the company was heading for another “New Coke” disaster.
But one executive says Coca-Cola has learned from past mistakes.
“We’ve learned that when you have a great thing, you don’t mess with it,” Rafael Acevedo, the company’s North America group director, told Cheddar, pointing out that, unlike with the 1985 marketing fiasco, the classic Diet Coke isn’t going anywhere.
What is changing is the packaging -- the company introduced slimmer cans -- and the flavor options. Ginger Lime, Feisty Cherry, Zesty Blood Orange, and Twisted Mango were added to the line up.
“We’re targeting spice seekers, and we want to target those people who are trying to look for bolder flavors and new experiences,” Acevedo said. “We saw that the sleek can actually connects with the new target as well, it makes the brand feel more premium and more modern. So all the research that we have is telling us that consumers absolutely love it.”
And Diet Coke certainly did its research. The company spent over two years working on this project and talked to about 10,000 consumers to figure out what would work.
For full interview [click here](https://cheddar.com/videos/diet-coke-refreshes-itself-for-2018).
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
The original Birkin bag created by Hermès for Jane Birkin in 1984 is up for auction in Paris. Sotheby’s expects the iconic bag to sell for hundreds of thousands of euros on Thursday.
Elon Musk’s artificial intelligence company is taking down antisemitic comments and other “inappropriate posts” made by its Grok chatbot, including some praising Adolf Hitler.
